1 result(s) displayed (1 - 1 of 1):
News of Celldex Therapeutics Inc. (NASDAQ:CLDX) acquiring CuraGen Corp. (NASDAQ:CRGN) for $94.5 million not only highlights a dealmaking trend we're tracking but signifies the need for a broader consolidation that could literally save lives.The acquisition of CuraGen will add a portfolio of oncology-focused, fully-owned antibodies to Celldex's precision-targeted immunotherapy platform....
Posted on May 29, 2009 12:30 PM
Movable Type search results powered by Fast Search